Evaluation of adherence to highly active antiretroviral therapy

Abstract

The efficacy of highly active antiretroviral therapy (HAART) with regard to the morbidity and mortality of patients infected with human immunodeficiency virus (HIV) is well known. Nevertheless, this efficacy is affected at both the individual and population levels when compliance with the treatment is inadequate.1,2 Improper adherence to HAART has been related to an increase in the viral load,3-5 which is a key element in the appearance of viral resistances